NP-C Therapeutics, LLC — Form D
NP-C Therapeutics, LLC of KING OF PRUSSIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-01. The offering totals $700K, of which $175K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-04-01
- Form: D
- Accession: 0001671127-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $700K
- Amount sold: $175K
- Remaining: $525K
- Minimum investment: $25K
- Investors: 4
- Date of first sale: 2016-03-18
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-260532
Issuer
- Name: NP-C Therapeutics, LLC
- CIK: 0001671127
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 640 FREEDOM BUSINESS CENTER DRIVE, KING OF PRUSSIA, PA, 19406
- Phone: 4846847574
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| William Claypool | Director | King of Prussia, PA |
| Dennis Willson | Director | King of Prussia, PA |
| William Claypool | Executive Officer | King of Prussia, PA |
| Ivan Joseph | Executive Officer | King of Prussia, PA |
| Dennis Willson | Executive Officer | King of Prussia, PA |
More